BioPharmSignal logoBioPharmSignal

Company Profile

Seer, Inc Stock Price, News & Catalysts

Ticker:
SEER
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

2.03 USD (+0.50%)

Close

Last updated: August 21, 2026

103M USD

Market cap

Why the stock is moving

As of Aug 21, 2026, SEER closed up 0.50% at $2.03. No new same-company headline was identified in the current news window.

Company overview

Deep Proteomics Company

Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development.

Proteograph Product Suite

The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a wide dynamic range.

Platform Adoption Model

Seer sells instruments and consumables while supporting service providers and research collaborators. Independent publications and customer-generated datasets provide external validation of the technology.

Future catalysts

    Recent news

    1. 01

      Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

    2. 02

      Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference

    3. 03

      Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

    4. 04

      Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

    5. 05

      Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    NAUT

    Nautilus Biotechnology

    PACB

    Pacific Biosciences

    OLK

    Olink

    TMO

    Thermo Fisher Scientific Inc

    TXG

    10x Genomics

    RVTY

    PerkinElmer

    DXCM

    DexCom, Inc.

    ISPC

    iSpecimen

    Frequently Asked Questions

    What is the current stock price of Seer, Inc (SEER)?

    Seer, Inc (SEER) most recently closed at 2.03 USD, a +0.50% move versus the previous session.

    What is the market cap of Seer, Inc (SEER)?

    Seer, Inc currently has a market capitalization of 103M USD on BioPharmSignal.

    What does Seer, Inc do?

    Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development. Proteograph Product Suite The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a wide dynamic...

    On which exchange is SEER stock listed?

    Seer, Inc (SEER) is associated with NASDAQ, United States, Biopharma.

    What is Deep?

    Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development.

    Which conditions is Seer, Inc targeting with Deep?

    Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development. Proteograph Product Suite The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a wide dynamic...

    What is Proteomics?

    Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development.

    What is Seer?

    Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development.